<DOC>
	<DOCNO>NCT02842736</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Cerene Cryotherapy Device reduce menstrual bleeding woman heavy menstrual bleeding ( menorrhagia ) due benign cause child bear complete .</brief_summary>
	<brief_title>A CLinical Study Evaluate Safety And Effectiveness CeRene DevIce Treat HeavY Menstrual Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>Refractory heavy menstrual bleeding definable organic cause Female subject age 25 50 year , inclusive Sounded length uterine cavity great 10 cm endometrial cavity great 6.5 cm Sufficient myometrial thickness Documented excessive menstrual blood loss within 3 month inform consent Premenopausal confirm follicle stimulate hormone ( FSH ) measurement Agrees use reliable form contraception follow ablation treatment Provides write informed consent use form approve review ethic committee Agrees followup exam data collection requirement Demonstrates understanding record menstrual blood loss use menstrual pictogram Has predictable , cyclic menstrual cycle Pregnant desire conceive Endometrial hyperplasia confirm histology Active endometritis Active pelvic inflammatory disease Active sexually transmit disease ( STD ) Presence bacteremia , sepsis , active systemic infection Active infection genitals , vagina , cervix , uterus Known/suspected abdominal , pelvic , gynecological malignancy within past 5 year Known clot defect bleed disorder Abnormal cytology Human papillomavirus ( HPV ) test treat accord local standard . Prior uterine surgery interrupt integrity uterine wall ( e.g. , transmural myomectomy classical cesarean section ) . Previous low transverse cesarean section myometrial wall thickness insufficient Previous endometrial ablation procedure Clinically significant adenomyosis indicate subject complaint , image , clinician 's judgment Presence implantable contraceptive device Currently medication could thin myometrial muscle Currently anticoagulants Abnormal obstructed cavity Currently use intrauterine device ( IUD ) unwilling remove IUD Postpartum â‰¤ 6months Considering participation research study investigational drug device would begin course investigational study Any general health mental , situation condition , opinion Investigator , could represent increase risk subject impact subject 's ability comply protocol requirement</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>heavy menstrual bleeding</keyword>
	<keyword>endometrial ablation</keyword>
</DOC>